Pharmosa Biopharm Inc. (6875.TWO)
TWD 44.8
(-0.44%)
TWD 44.8
(-0.44%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -829.69 Million TWD | -27.39% |
| 2022 | -651.31 Million TWD | -53.48% |
| 2021 | -424.37 Million TWD | -46.28% |
| 2020 | -290.1 Million TWD | -241.72% |
| 2019 | -84.89 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.73 Billion TWD | -108.82% |
| 2024 Q2 | -1.62 Billion TWD | 6.3% |
| 2023 Q3 | -983.95 Million TWD | -110.15% |
| 2023 Q2 | -468.2 Million TWD | -169.62% |
| 2023 FY | -829.69 Million TWD | -27.39% |
| 2023 Q1 | 672.51 Million TWD | 203.25% |
| 2023 Q4 | -829.69 Million TWD | 15.68% |
| 2022 Q4 | -651.31 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Sagittarius Life Science Corp | -120.57 Million TWD | -588.14% |
| Neith Corporation | -150.31 Million TWD | -451.982% |
| TaiRx, Inc. | -147.86 Million TWD | -461.098% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -161.387% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -717.541% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -402.307% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -214.075% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -322.456% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 2160.523% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 2813.356% |
| Visgeneer Inc. | 31.28 Million TWD | 2752.122% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | -21.905% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -518.009% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -1338.985% |
| Enimmune corporation | -314.15 Million TWD | -164.099% |
| EirGenix Inc. | -4.58 Billion TWD | 81.916% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -878.835% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 786.426% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -4087.604% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 1734.696% |
| RBC Bioscience Corporation | 422.18 Million TWD | 296.523% |
| BiOptic Inc. | 12.59 Million TWD | 6689.025% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -976.904% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 363.5% |
| Mycenax Biotech Inc. | 207 Million TWD | 500.799% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 233.49% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 2708.35% |
| Level Biotechnology Inc. | -453.9 Million TWD | -82.79% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 265.988% |
| GlycoNex Incorporation | -148.56 Million TWD | -458.462% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 701.246% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -215.974% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 74.219% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 12.147% |
| VBI | -25.31 Million TWD | -3177.334% |
| CHO Pharma, Inc. | -203.79 Million TWD | -307.126% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -1189.921% |
| NaviFUS Corp. | -123.12 Million TWD | -573.838% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 1220.431% |
| Sinew Pharma Inc. | -160.34 Million TWD | -417.441% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -242.999% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -145.926% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | -101.07% |
| AP Biosciences Inc | -196.52 Million TWD | -322.174% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 220.466% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -7154.437% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 161.127% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | -99.984% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -296.34% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -476.722% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -151.009% |
| TCI GENE Inc. | -689.25 Million TWD | -20.376% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -597.582% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 36.627% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 4150.627% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -714.46% |
| PharmaEngine, Inc. | -860.8 Million TWD | 3.615% |
| Savior Lifetec Corporation | -812.54 Million TWD | -2.11% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -176.593% |
| OBI Pharma, Inc. | -398.22 Million TWD | -108.348% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | -127.052% |
| Acepodia, Inc. | -6.02 Billion TWD | 86.218% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 75.61% |